Trial Profile
Effect of risedronate combined with vitamin K2 in patients with osteoporosis due to the steroid therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Vitamin K2 (Primary) ; Vitamin K
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 12 Oct 2011 New trial record